中国医学工程2024,Vol.32Issue(10) :34-37.DOI:10.19338/j.issn.1672-2019.2024.10.007

经额叶造瘘侧脑室脉络膜裂入路治疗丘脑胶质细胞瘤

Treatment of thalamic glioma through choroidal fissure approach of lateral ventricle of frontal lostomy

李佳俤 牟磊 秦军 雷军荣
中国医学工程2024,Vol.32Issue(10) :34-37.DOI:10.19338/j.issn.1672-2019.2024.10.007

经额叶造瘘侧脑室脉络膜裂入路治疗丘脑胶质细胞瘤

Treatment of thalamic glioma through choroidal fissure approach of lateral ventricle of frontal lostomy

李佳俤 1牟磊 2秦军 2雷军荣2
扫码查看

作者信息

  • 1. 锦州医科大学,辽宁锦州 121000;湖北医药学院附属医院(十堰市太和医院)神经肿瘤科,湖北十堰 442000
  • 2. 湖北医药学院附属医院(十堰市太和医院)神经肿瘤科,湖北十堰 442000
  • 折叠

摘要

目的 探讨经额叶造瘘侧脑室脉络膜裂入路治疗丘脑胶质细胞瘤中的临床应用体会.方法 对21例经额叶造瘘侧脑室脉络膜裂入路治疗丘脑胶质细胞瘤患者进行回顾性研究,总结分析其临床资料、手术方法及术后随访资料.结果 17例肿瘤均实现全切,4例次全切,术后5例脑积水,3例颅内感染,术前18例头痛、头晕患者症状消失或改善,6~40个月随访,平均24.7个月,2例次全切患者肿瘤复发,余患者无复发,1例次全切患者再次手术切除肿瘤.术后新发症状均不同程度改善.结论 经额叶造瘘侧脑室脉络膜裂入路治疗丘脑胶质细胞瘤的临床应用中效果满意.

Abstract

[Objective]To investigate the clinical application of the choroidal fissure approach to the lateral ventricle of the frontal lostomy in the treatment of thalamic glioblastoma.[Methods]The clinical data,surgical methods and postoperative follow-up data of 21 patients with thalamic glioblastoma treated by frontal lostomy lateral ventricle choroidal fissure approach were analyzed retrospectively.[Results]Total resection was achieved in all 17 cases,and subtotal resection in 4 cases.There were postoperative hydrocephalus in 5 cases and intracranial infection in 3 cases.Symptoms disappeared or improved in 18 patients with headache and dizziness before surgery.Patients were followed up for 6 to 40 months,with an average of 24.7 months.Tumor recurrence in 2 patients with subtotal resection,and no recurrence in the remaining patients,and tumor resection again in 1 patient with subtotal resection.Postopcrative new symptoms were improved to different degrees.[Conclusion]The clinical application of transfrontal lostomy lateral ventricle choroidal fissure approach in the treatment of thalamic glioblastoma is satisfactory.

关键词

丘脑肿瘤/颅底/显微手术

Key words

trigeminal schwannoma/skull base/microsurgery

引用本文复制引用

出版年

2024
中国医学工程
中国医药生物技术协会 卫生部肝胆肠外科研究中心

中国医学工程

影响因子:0.504
ISSN:1672-2019
段落导航相关论文